A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer
Authors
Keywords
Overall survival, Hemoglobin, Biological markers, Vascular endothelial growth factor, Prognostic factors, Gesamtüberleben, Hämoglobin, Biologische Marker, Vaskulärer endothelialer Wachstumsfaktor, Prognosefaktoren
Journal
STRAHLENTHERAPIE UND ONKOLOGIE
Volume 190, Issue 3, Pages 276-282
Publisher
Springer Nature
Online
2013-12-09
DOI
10.1007/s00066-013-0484-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation between tumor oxygenation and18F-fluoromisonidazole PET data simulated based on microvessel images
- (2013) David Mönnich et al. ACTA ONCOLOGICA
- GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: Subgroup analysis of the prospective randomized CHARTWEL trial
- (2013) Maher Soliman et al. RADIOTHERAPY AND ONCOLOGY
- The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)
- (2013) David L. Ball et al. RADIOTHERAPY AND ONCOLOGY
- Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer
- (2012) Daniel Zips et al. RADIOTHERAPY AND ONCOLOGY
- Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines
- (2012) D. Schilling et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Prognostic value of HIF-1α expression during fractionated irradiation
- (2012) L. Helbig et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Hypoxia-related molecules HIF-1α, CA9, and osteopontin
- (2012) O.P. Erpolat et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Acute versus chronic hypoxia in tumors
- (2012) C. Bayer et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Osteopontin as a marker of weight loss in lung cancer
- (2011) Fisun Karadag et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro
- (2011) Adrian Staab et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Prognostic Value of Radiobiological Hypoxia during Fractionated Irradiation for Local Tumor Control
- (2011) Daniel Zips et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients
- (2010) Matthias Bache et al. BMC CANCER
- High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
- (2010) M İlie et al. BRITISH JOURNAL OF CANCER
- Development and Validation of a Prognostic Model Using Blood Biomarker Information for Prediction of Survival of Non–Small-Cell Lung Cancer Patients Treated With Combined Chemotherapy and Radiation or Radiotherapy Alone (NCT00181519, NCT00573040, and NCT00572325)
- (2010) Cary Dehing-Oberije et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer
- (2010) Justin D. Blasberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer
- (2010) L. A. Byers et al. MOLECULAR CANCER THERAPEUTICS
- Plasma Osteopontin Levels in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy
- (2009) Igor Snitcovsky et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts
- (2009) Ala Yaromina et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
- (2008) M. Bache et al. CURRENT MEDICINAL CHEMISTRY
- Correlation Between Tumor Growth Delay and Expression of Cancer and Host VEGF, VEGFR2, and Osteopontin in Response to Radiotherapy
- (2008) Timothy D. Solberg et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003
- (2008) Philip C. Mack et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of HIF-1α Expression in Patients with Definitive Radiotherapy for Cervical Cancer
- (2008) Kathrin Dellas* et al. STRAHLENTHERAPIE UND ONKOLOGIE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started